Corn silk tea for hypertension: A systematic review and meta-analysis of randomized controlled trials

Evidence-based Complementary and Alternative Medicine

Volumn 2019, Issue , 2019, Pages

  Shi, Shihua ^a   Li, Siming ^b   Li, Weihao ^c   Xu, Hao ^b  

^a University of Traditional Chinese Medicine   (China)

^b XIYUAN HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CORN SILK TEA; HERBACEOUS AGENT; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; CLINICAL OUTCOME; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; HYPERTENSIVE PATIENT; META ANALYSIS; PATIENT SAFETY; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 85060804734     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2019/2915498     Document Type: Review

References (35)

1. K. T. Mills, J. D. Bundy, and T. N. Kelly, "Global disparities of hypertension prevalence and control," Circulation, vol. 134, no. 6, pp. 441-450, 2016.
2. DC. Muller, N. Murphy, and M. Johansson, "Modifiable causes of premature death in middle-age in Western Europe: Results from the EPIC cohort study," BMCl Medicine, vol. 14, no. 1, pp. 14-87, 2016.
3. U. Kintscher, "The burden of hypertension," EuroIntervention, vol. 9, pp. R12-R15, 2013.
4. H. Pang, B. Han, Q. Fu, L. Hao, and Z. Zong, "Association between homocysteine and conventional predisposing factors on risk of stroke in patients with hypertension," Scientific Reports, vol. 8, no. 1, p. 3900, 2018.
5. N. R. Poulter, D. Prabhakaran, and M. Caulfield, "Hypertension," The Lancet, vol. 386, no. 9995, pp. 801-812, 2015.
6. R. G. Kalaitzidis and G. L. Bakris, "Prehypertension: Is it relevant for nephrologists," Kidney International, vol. 77, no. 3, pp. 194-200, 2010.
7. C. M. Lawes, S. V. Hoorn, and A. Rodgers, "Global burden of blood-pressure-related disease, 2001," The Lancet, vol. 371, no. 9623, pp. 1513-1518, 2008.
8. M. H. Forouzanfar, P. Liu, G. A. Roth et al., "Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015," JAMA, vol. 317, no. 2, pp. 165-182, 2017.
9. M. Ezzati, A. D. Lopez, A. Rodgers, S. VanderHoorn, and C. J. L. Murray, "Selected major risk factors and global and regional burden," The Lancet, vol. 360, no. 9343, pp. 1347-1360, 2002.
10. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins, "Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies," The Lancet, vol. 360, no. 9349, pp. 1903-1913, 2002.
11. N. R. C. Campbell, D. T. Lackland, and M. L. Niebylski, "High blood pressure: why prevention and control are urgent and important - A 2014 fact sheet from the world hypertension league and the international society of hypertension," The Journal of Clinical Hypertension (Greenwich), vol. 16, no. 8, pp. 551-553, 2014.
12. J. Stokes, W. B. Kannel, P. A. Wolf, R. B. D'Agostino, and L. Adrienne Cupples, "Blood pressure as a risk factor for cardiovascular disease the framingham study-30 years of follow-up," Hypertension, vol. 13, no. 5, pp. I13-I18, 1989.
13. J. Wang and X. Xiong, "Evidence-Based Chinese Medicine for Hypertension," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 978398, 12 pages, 2013.
14. E. Ernst, "Complementary/alternative medicine for hypertension: A mini-review," Wiener Medizinische Wochenschrift, vol. 123, pp. 386-391, 2005.
15. R. A. Bell, C. K. Suerken, J. G. Grzywacz, W. Lang, S. A. Quandt, and T. A. Arcury, "CAM use among older adults age 65 or older with hypertension in the United States: General use and disease treatment," The Journal of Alternative and Complementary Medicine, vol. 12, no. 9, pp. 903-909, 2006.
16. T.-Y. Ho, C.-C. Li, H.-Y. Lo, F.-Y. Chen, and C.-Y. Hsiang, "Corn silk extract and its bioactive peptide ameliorated lipopolysaccharide-induced inflammation in mice via the nuclear factor-κB signaling pathway," Journal of Agricultural and Food Chemistry, vol. 65, no. 4, pp. 759-768, 2017.
17. L. Que and H. R. Li, "Discussion on the Herbal Prescription Features in Materia Medica of South Yunnan," Journal of Yunnan University of TCM, vol. 34, no. 1, pp. 8-13, 2011.
18. W. I. WanRosli, A. R. Nurhanan, S. S. J. Mohsin, andC. G. Farid, "Aqueous, alcoholic treated and proximate analysis of maydis stigma (Zea mays hairs)," Annals of Microscopy, vol. 8, pp. 66-72, 2008.
19. D. A. Farsi, C. S. Harris, L. Reid et al., "Inhibition of nonenzymatic glycation by silk extracts from a Mexican land race and modern inbred lines of maize (Zea mays)," Phytotherapy Research, vol. 22, no. 1, pp. 108-112, 2008.
20. C. W. Lee, J. Y. Seo, S. Kim, J. Lee, J. W. Choi, and Y. I. Park, "Corn silk maysin ameliorates obesity in vitro and in vivo via suppression of lipogenesis, differentiation, and function of adipocytes," Biomedicine & Pharmacotherapy, vol. 93, pp. 267-275, 2017.
21. H. Liu andY. Jin, "The clinical effect of corn silk in the treatment of gestational hypertension," China Rural Health, vol. 3, pp. 68-69, 2017.
22. B. H. Yu, "A randomized controlled trial of nifedipine plus corn silk for treatment of primary hypertension," World Latest Medicine Information (Electronic Version), vol. 17, no. 39, p. 86, 2017.
23. W. Z. Gu and C. F. Tan, "32 cases ofH-type hypertension treated with modified corn silk tea and folicin," Traditional Chinese Medicine Research, vol. 8, no. 6, pp. 27-28, 2015.
24. Y. Dong, L. J. Gong, J. L. Lu, andP. L. Chen, "Clinical trial of corn silk for the treatment of initial diagnosis of hypertension," Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 7, no. 6, p. 643, 2009.
25. A. T. Guli, H. Liu, and Y. Jin, "Clinical analysis of corn silk used tomild and severe preeclampsia," Journal of the ChineseMedical Association, vol. 33, pp. 99-101, 2017.
26. D. Moher, A. Liberati, and J. Tetzlaff, "Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement," Journal of Clinical Epidemiology, vol. 62, no. 10, pp. 1006-1012, 2009.
27. A. V. Chobanian, G. L. Bakris, H. R. Black et al., "The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report," The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560-2572, 2003.
28. J. P. T. Higgins and S. Green, "Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0 [updatedMarch 2011], The Cochrane Collaboration," 2011, http://handbook-5-1 cochrane. org, [Accessed on 7th Oct 2018].
29. M. Ozarowski, P. Mikolajczak, R. Kujawski et al., "Pharmacological effect of quercetin in hypertension and its potential application in pregnancy-induced hypertension: Review of in vitro, in vivo, and clinical studies," Evidence-Based Complementary and Alternative Medicine, vol. 2018, Article ID 7421489, p. 19, 2018.
30. X. Xiong, X. Yang, and L. Duan, "Traditional chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats," Scientific Reports, vol. 7, no. 22, pp. 42965-42977, 2017.
31. A. Liu, Y. J. Chu, X. Wang et al., "Serum metabolomics study based on LC-MS and antihypertensive effect of uncaria on spontaneously hypertensive rats," Evidence-Based Complementary and Alternative Medicine, vol. 2018, Article ID 9281946, 11 pages, 2018.
32. J. Wang and X. Xiong, "Control Strategy on Hypertension in Chinese Medicine," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID284847, 6pages, 2012.
33. A. Vickers, N. Goyal, R. Harland, and R. Rees, "Do certain countries produce only positive results? A systematic review of controlled trials," Controlled Clinical Trials, vol. 19, no. 2, pp. 159-166, 1998.
34. F. Grases, J. G. March, M. Ramis, and A. Costa-Bauzá, "The influence of Zea mays on urinary risk factors for kidney stones in rats," Phytotherapy Research, vol. 7, no. 2, pp. 146-149, 1993.
35. O.-J. Min, B. R. Sharma, C. M. Park, and D. Y. Rhyu, "Effect of myadis stigma water extract on adipogenesis and blood glucose in 3T3-L1 adipocytes and db/db mice," Korean Journal of Pharmacognosy, vol. 42, no. 2, pp. 201-208, 2011.